Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Cureus ; 16(5): e59984, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38854181

RESUMO

The free fibula flap (FFF), based on the peroneal artery (PA) system, is the gold standard for mandibular reconstruction. Various anatomical variations in the infra-popliteal lower limb vascular system exist. These variations present as an intraoperative surprise to surgeons even after an unremarkable clinical vascular examination of the leg. Here, we report one such case, where we performed successful mandibular reconstruction after encountering a Type IIIA variation of infra-popliteal arterial vasculature.

2.
Cureus ; 16(4): e58881, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38800208

RESUMO

Central giant cell granuloma (CGCG) is a bone lesion characterized by fibrous tissue containing areas of bleeding, giant cells with multiple nuclei, and trabeculae of woven bone. It is considered to be a local bone repair response, possibly triggered by inflammation, bleeding, or local injury. CGCG is more prevalent in females and can occur across a wide age range, typically diagnosed at a young age. Mandibular involvement is more common than maxillary involvement, with most lesions in the posterior region often extending into the ascending ramus. Management of aggressive CGCG can involve non-surgical (medical) and surgical treatment modalities. Surgical approaches vary from simple curettage to en bloc resection depending on various factors discussed in this case report.

3.
Cureus ; 15(10): e47438, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-38021869

RESUMO

Neurilemmomas are benign, slowly growing tumors originating from Schwann cells in peripheral nerves. The precise cause is unclear. They commonly occur in the head and neck region (25-48% of cases) and rarely in the oral cavity (1%). While lingual schwannomas can develop at any age, they are most frequently seen between the ages of 30 and 60 years. In this case, a 19-year-old female was diagnosed with a lingual schwannoma. She had experienced painless swelling along the left side of her tongue for two years. The examination revealed a non-tender, soft to firm, 2x1 cm lump on the left side of the tongue, covered by healthy mucosa, with no signs of cervical lymph node enlargement. The lesion was completely excised under local anesthesia for histopathological evaluation. Histological examination revealed spindle cells with slender, undulating nuclei in Antoni A and B regions. The prominent nuclear palisading feature typical of schwannomas was evident.

4.
BMJ Open Qual ; 12(2)2023 04.
Artigo em Inglês | MEDLINE | ID: mdl-37055172

RESUMO

Every day in hospitals around the world, millions of interspecialty referrals are made to obtain advice on the optimal care and management of patients. In the UK, the brunt of this work is undertaken by junior doctors with less clinical experience than the specialist colleagues to which they refer. A survey of 283 junior doctors revealed that colleagues were underconfident when making referrals and struggled to know which specialty to contact, how to reach the specialty and what clinical information to include in the referral. More concerningly, 10% of those surveyed had experienced bullying or belittling behaviours and verbal aggression from colleagues when referring.The aim of this project was to design and implement a referrals toolkit for junior doctors to improve confidence making referrals and time to interspecialty advice, to improve patient care. Process mapping to understand the constituents of good referrals was combined with a failure modes and effects analysis describing how referrals fail to identify areas for intervention.A specialty referrals guide with all specialty contact information was created at the trust, demonstrating an increase in junior doctor median confidence from 3/5 (n=20) to 5/5 (n=23) (p<0.001); 65% found it quicker to refer with the guide and 81% found an improved time to discharge. A referrals cheat sheet was also created, containing specialty-specific information to be included when making a referral. This has been downloaded over 23 000 times from around the globe. Of survey respondents (n=43), 74% noted improved confidence in making referrals, 26% noted faster time to specialty advice and 19% found a positive impact on patient discharges. Overall, the referrals toolkit has been beneficial for both junior doctors and the patients for which they care and has been accessed by over 50% of new foundation doctors in 2021 and 2022.


Assuntos
Médicos , Humanos , Encaminhamento e Consulta , Assistência ao Paciente , Corpo Clínico Hospitalar , Inquéritos e Questionários
5.
Hepatology ; 77(1): 186-196, 2023 01 01.
Artigo em Inglês | MEDLINE | ID: mdl-35712794

RESUMO

BACKGROUND AND AIMS: Immunity to SARS-CoV-2 can be infection or vaccine-induced. Cirrhosis is associated with vaccine hyporesponsiveness, but whether there is decreased immunity after SARS-CoV-2 infection in unvaccinated patients with cirrhosis is unknown.The objective of our study was to compare infection-induced and vaccine-induced immunity against COVID-19 among patients with cirrhosis. METHODS: This was a retrospective cohort study among US Veterans with cirrhosis between November 27, 2020, and November 16, 2021, comparing a vaccine-induced immunity group, defined as participants without a documented SARS-CoV-2 infection but fully vaccinated with two doses of an mRNA vaccine, and infection-associated immunity group, defined as unvaccinated participants who had a positive SARS-CoV-2 polymerase chain reaction (PCR). Both groups were propensity score matched for observed characteristics, including location, and the date of the immunity acquiring event, to control for the community prevalence of COVID-19 variants. The outcome was a positive SARS-CoV-2 PCR more than 60 days after previous infection in the infection-induced, or after full vaccination in the vaccine-induced immunity group. RESULTS: We compared 634 participants in the infection-induced immunity group with 27,131 participants in the vaccine-induced immunity group using inverse propensity of treatment weighting. Vaccine-induced immunity was associated with a reduced odds of developing SARS-CoV-2 infection (adjusted hazard ratio [aHR], 0.18; 95% confidence interval [CI], 0.16-0.20, p < 0.0001). On multivariable logistic regression, vaccine-induced immunity was associated with reduced odds of developing symptomatic (adjusted odds ratio [aOR], 0.36; 95% CI, 0.33-0.41, p < 0.0001), moderate/severe/critical (aOR, 0.27; 95% CI, 0.22-0.31, p < 0.0001), and severe or critical COVID-19 (aOR, 0.20; 95% CI, 0.16-0.26, p < 0.001), compared with infection-induced immunity. CONCLUSIONS: In participants with cirrhosis, vaccine-induced immunity is associated with reduced risk of developing COVID-19, compared with infection-induced immunity.


Assuntos
COVID-19 , Vacinas , Humanos , COVID-19/epidemiologia , COVID-19/prevenção & controle , Estudos Retrospectivos , SARS-CoV-2 , Cirrose Hepática
7.
J Hepatol ; 77(5): 1349-1358, 2022 11.
Artigo em Inglês | MEDLINE | ID: mdl-36181987

RESUMO

BACKGROUND & AIMS: Cirrhosis is associated with immune dysregulation and hyporesponsiveness to several vaccines including those against COVID-19. Our aim was to compare outcomes between patients with cirrhosis who received 3 doses of either the Pfizer BNT162b2 mRNA or Moderna mRNA-1273 vaccines to a propensity-matched control group of patients at similar risk of infection who received 2 doses. METHODS: This was a retrospective cohort study of patients with cirrhosis who received 2 or 3 doses of a COVID-19 mRNA vaccine at the Veterans Health Administration. Participants who received 3 doses of the vaccine (n = 13,041) were propensity score matched with 13,041 controls who received 2 doses, and studied between July 18, 2021 and February 11, 2022, when B.1.617.2 (delta) and B.1.1.529 (omicron) were the predominant variants. Outcomes were aggregated as all cases with COVID-19, symptomatic COVD-19, with at least moderate COVID-19, or severe or critical COVID-19. RESULTS: Receipt of the third dose of a COVID-19 mRNA vaccine was associated with an 80.7% reduction in COVID-19 (95% CI 39.2-89.1, p <0.001), an 80.4% reduction in symptomatic COVID-19, an 80% reduction in moderate, severe or critical COVID-19, (95% CI 34.5-87.6%, p = 0.005), a 100% reduction in severe or critical COVID-19 (95% CI 99.2-100.0, p = 0.01), and a 100% reduction in COVID-19-related death (95% CI 99.8-100.0, p = 0.007). The magnitude of reduction in COVID-19 was greater with the third dose of BNT 162b2 than mRNA-1273 and among participants with compensated rather than decompensated cirrhosis. CONCLUSIONS: Administration of a third dose of a COVID-19 mRNA vaccine was associated with a more significant reduction in COVID-19 in patients with cirrhosis than in the general population, suggesting that the third dose can overcome vaccine hyporesponsiveness in this population. LAY SUMMARY: Cirrhosis is associated with decreased responsiveness to several vaccines, including those against COVID-19. In this study of 26,082 participants with cirrhosis during the delta and omicron surge, receipt of the third dose of the vaccine was associated with an 80% reduction in COVID-19, a 100% reduction in severe/critical COVID-19, and a 100% reduction in COVID-19-related death. These findings support the importance of a third dose of mRNA vaccine among patients with cirrhosis.


Assuntos
Vacinas contra COVID-19 , COVID-19 , Vacinas , Humanos , Vacina BNT162 , COVID-19/epidemiologia , COVID-19/prevenção & controle , Vacinas contra COVID-19/efeitos adversos , Cirrose Hepática/complicações , Vacinas de mRNA , Estudos Retrospectivos , SARS-CoV-2 , Vacinas Sintéticas
9.
Dig Dis Sci ; 65(12): 3448-3455, 2020 12.
Artigo em Inglês | MEDLINE | ID: mdl-33057945

RESUMO

Randomized trials have demonstrated that ablation of dysplastic Barrett's esophagus can reduce the risk of progression to cancer. Endoscopic resection for early stage esophageal adenocarcinoma and squamous cell carcinoma can significantly reduce postoperative morbidity compared to esophagectomy. Unfortunately, current endoscopic surveillance technologies (e.g., high-definition white light, electronic, and dye-based chromoendoscopy) lack sensitivity at identifying subtle areas of dysplasia and cancer. Random biopsies sample only approximately 5% of the esophageal mucosa at risk, and there is poor agreement among pathologists in identifying low-grade dysplasia. Machine-based deep learning medical image and video assessment technologies have progressed significantly in recent years, enabled in large part by advances in computer processing capabilities. In deep learning, sequential layers allow models to transform input data (e.g., pixels for imaging data) into a composite representation that allows for classification and feature identification. Several publications have attempted to use this technology to help identify dysplasia and early esophageal cancer. The aims of this reviews are as follows: (a) discussing limitations in our current strategies to identify esophageal dysplasia and cancer, (b) explaining the concepts behind deep learning and convolutional neural networks using language appropriate for clinicians without an engineering background, (c) systematically reviewing the literature for studies that have used deep learning to identify esophageal neoplasia, and (d) based on the systemic review, outlining strategies on further work necessary before these technologies are ready for "prime-time," i.e., use in routine clinical care.


Assuntos
Inteligência Artificial , Esôfago de Barrett/patologia , Neoplasias Esofágicas , Biópsia/normas , Diagnóstico por Computador/métodos , Diagnóstico Diferencial , Neoplasias Esofágicas/patologia , Neoplasias Esofágicas/terapia , Esofagectomia/métodos , Esofagoscopia/métodos , Humanos
10.
Curr Diab Rep ; 19(10): 90, 2019 08 30.
Artigo em Inglês | MEDLINE | ID: mdl-31471810

RESUMO

PURPOSE OF REVIEW: Obesity is increasing at an alarming rate and now poses a global threat to humankind. In recent years, we have seen the emergence of medical devices to combat the obesity epidemic. These therapeutic strategies are discussed in this review dividing them into gastric and duodenal therapies. RECENT FINDINGS: Traditionally, medical devices for obesity such as the intragastric balloon have focused on reducing gastric size, but more recently there has been a shift towards developing devices that modulate neural and hormonal responses to induce early satiety thus reducing oral intake. Medical devices for obesity treatment may have a role in those patients who are struggling to control their weight despite significant lifestyle modifications such as diet and exercise and who decline or are unfit for bariatric surgery. For the wider adoption and integration of these devices in the obesity treatment paradigm, more long-term efficacy and safety data from randomised controlled trials are required.


Assuntos
Cirurgia Bariátrica/instrumentação , Obesidade/cirurgia , Duodeno/cirurgia , Humanos , Estômago/cirurgia
11.
Adv Med Educ Pract ; 10: 357-359, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-31213940

RESUMO

Evidence shows dwindling levels of bedside teaching for medical students in the UK, especially in district general hospitals. Lack of individual responsibility has resulted in disengagement in teaching. Based on a quality improvement project (QIP) at a District General Hospital, we suggest some ways this could be addressed. We suggest here that harnessing support from the medical education lead, incentivizing teaching, allocating student-junior doctor groups to harbor personal responsibility, providing a supportive framework, and educating about barriers to teaching can all be used to develop an effective teaching program.

12.
Pneumologia ; 64(1): 14-7, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26016051

RESUMO

Currently there is an unmet need for more objective assessments that could determine COPD severity. Ideally such objective assessments could also anticipate COPD exacerbations in order to decrease the need for repeated hospital admissions. In this review we outline how patients' neural respiratory drive (NRD) may be determined using the electromyography of the diaphragm as an objective measurement of COPD severity. Respiratory muscle NRD is indeed less influenced by patients' voluntary effort limitation than for example when testing for exercise tolerance in which case the patients themselves decide when to stop. Exercise tolerance tests are better correlated with muscle weakness rather than COPD severity per se. NRD would also be less dependent upon patients' subjective perception of the severity of their breathlessness. A key further advantage is that recent studies showed that the diaphragm electromyography measurements using electrodes placed on the skin are correlated with those obtained using specific electrodes, therefore this method is non-invasive and more acceptable for routine clinical practice. Thus, NRD measurements could be used in COPD in a similar way as electrocardiography is used to evaluate and monitor ischemic heart disease. NRD measurements could therefore complement more established instruments such as lung function tests, FEV1, exercise tolerance tests, the BODE index etc. in COPD. This could lead to better COPD management and reduce the acute exacerbations which are amongst the most common causes of repeated hospital admissions and consume significant resources.


Assuntos
Diafragma/fisiopatologia , Eletromiografia , Teste de Esforço , Tolerância ao Exercício , Doença Pulmonar Obstrutiva Crônica/diagnóstico , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Doença Aguda , Diafragma/inervação , Progressão da Doença , Dispneia/etiologia , Dispneia/fisiopatologia , Eletrodos Implantados , Eletromiografia/métodos , Teste de Esforço/métodos , Humanos , Músculos Intercostais/fisiopatologia , Monitorização Fisiológica , Doença Pulmonar Obstrutiva Crônica/complicações , Doença Pulmonar Obstrutiva Crônica/prevenção & controle , Reprodutibilidade dos Testes , Testes de Função Respiratória , Medição de Risco , Índice de Gravidade de Doença
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...